The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Acute Sex Steroid Withdrawal Reduces Insulin Sensitivity in Healthy Men with Idiopathic Hypogonadotropic Hypogonadism
Abstract
CONTEXT: Evidence suggests that testosterone (T) influences insulin sensitivity in men. The mechanism of this effect is unclear but is thought to involve changes in body composition. OBJECTIVE: The aim of this study was to determine whether acute sex steroid withdrawal decreases insulin sensitivity in young, healthy men with idiopathic hypogonadotropic hypogonadism (IHH). DESIGN: This was a 2-wk prospective study. SETTING: The study was conducted at a General Clinical Research Center. PATIENTS: Twelve men with IHH (age 40.8 +/- 2.8 yr) were studied: 1) on hormone replacement with normal T levels and 2) 2 wk after discontinuing therapy. MAIN OUTCOME MEASURES: Each evaluation comprised a 75-g oral glucose tolerance test with assessment of insulin sensitivity (fasting insulin levels, homeostatic model assessment for insulin resistance, and Matsuda insulin sensitivity index) and insulin secretion (corrected insulin response). Serum cortisol, leptin, adiponectin, free fatty acids, IL-6, C-reactive protein, and TNF-alpha levels were also measured. RESULTS: Body mass index was unchanged (27.1 +/- 1.1 to 27.2 +/- 1.1 kg/m(2)). Serum T levels decreased from 529 +/- 65 to 28 +/- 8 ng/dl (P < 0.00005). Fasting insulin levels increased from 4.9 +/- 0.7 to 6.2 +/- 0.6 microU/ml (P = 0.005), homeostatic model assessment of insulin resistance increased from 1.07 +/- 0.2 to 1.4 +/- 1.01 (P < 0.005), and insulin sensitivity index decreased from 11.0 +/- 2.3 to 7.5 +/- 0.7 (P < 0.05). There was a trend for fasting glucose levels to increase, 86.7 +/- 1.3 to 90.8 +/- 1.7 mg/dl (P = 0.09). IL-6 levels increased from 1.2 +/- 0.2 to 2.4 +/- 0.5 pg/ml (P < 0.01), whereas TNF-alpha levels decreased from 1.0 +/- 0.1 to 0.6 +/- 0.1 pg/ml (P < 0.05). No other significant changes were observed. CONCLUSIONS: 1) Acute sex steroid withdrawal reduces insulin sensitivity in young healthy IHH men. 2) The acuity of the hypogonadism and absence of changes in body mass index or leptin levels suggest that sex steroids modulate insulin sensitivity in the absence of apparent or detectable changes in body composition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but there is evidence that acute testosterone fall during deprivation therapy is directly related to a worsening in insulin sensitivity (53).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [53]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Cited by
Sorted by citations
Items 201–219 of 219
Recent perspectives on the age-related decline of testosterone
Gooren, L. J. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2007.12.003 · Cited by 1
Chin, K. (2019) · Medicine & health · doi:10.17576/mh.2019.1402.15 · Cited by 1
Kallmann Syndrome : Clinical and molecular genetic features in Finland
Laitinen, E. (2012) · Työväentutkimus Vuosikirja · Cited by 1
Traish, A. M., Saad, F., & Guay, A. T. (2008) · Cited by 1
Testosterone replacement therapy
Surampudi, V., & Swerdloff, R. S. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000058 · Cited by 1
Obesity, metabolic syndrome, male hypogonadism and cardiovascular risk
Corona, G., Lotti, F., Sforza, A., Maggi, M., & Chiarini, V. (2009) · Italian Journal of Medicine · doi:10.1016/j.itjm.2009.09.002
Ganie, M. A., Rahaman, S. H., & Raizada, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-3695-8_23
Characterizing the Role of Insulin Signalling in Advanced Prostate Cancer
Sarkar, P. L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.110524
kumaran, D. S. S. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i10.167
Non‐alcoholic fatty liver disease in men
Michael, E., & Alazawi, W. (2019) · Trends in Urology & Men s Health · doi:10.1002/tre.718
Cignarelli, A., Perrini, S., & Giorgino, F. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-51410-5_18
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32830c6b8e
Vélayoudom‐Céphise, F. (2012) · doi:10.70675/25757912z8b37z4273zb275zcc29c39176f2
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis
Adler, E. R., Mohammad, A., Kumar, P., Rounbehler, R. J., Churchman, M. L., Graham, L. S., Singer, E. A., Salhia, B., Ayanambakkam, A., Nepple, K. G., et al. (2026) · Cancers · doi:10.3390/cancers18101636
Andersen, M. L., SANCHES, J. B., Alvarenga, T. A., Toricelli, M., Vasco, M. B., & Tufik, S. E. R. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02981-6
Shi, Y., & Shen, Y. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.051048
Kemp, T. (2014) · UpSpace Institutional Repository (University of Pretoria)
Metadata
- Authors
- Yialamas, M. A., Dwyer, A. A., Hanley, E., Lee, H., Pitteloud, N., & Hayes, F. J.
- Affiliations
- Massachusetts General Hospital (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-11-01
- Volume
- 92
- Issue
- 11
- Pages
- 4254-4259
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2068756512
- Cited by
- 220
- References
- 62
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 12 · 2019: 10 · 2018: 14 · 2017: 15 · 2016: 9 · 2015: 9 · 2014: 16 · 2013: 14 · 2012: 14
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r03dk064276-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03 DK064276 A 01)
- National Center for Research Resources (M01RR001066)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- idiopathic hypogonadotropic hypogonadism, testosterone withdrawal, insulin sensitivity, insulin resistance, testosterone replacement therapy, insulin secretion, interleukin-6, TNF-α, C-reactive protein, adiponectin, leptin, cortisol, body composition, young men, oral glucose tolerance test, HOMA-IR
- MeSH terms
- Adult, Aged, Body Composition, Gonadotropins, Humans, Hypogonadism, Insulin Resistance, Male, Middle Aged, Gonadal Steroid Hormones, Substance Withdrawal Syndrome, Testosterone, Body Mass Index, Cytokines, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review